Acuvail
| Acuvail | |
|---|---|
| DOSAGE | Seasonal Allergic Conjunctivitis: 1 gtt BID for ocular itching |
| Post-Op Inflammation (Cataract): 1 gtt BID in operated eye (start 24 hrs PRIOR to surgery), day of surgery and then continue for 2 weeks | |
| GENERIC | ketorolac tromethamin 0.45% |
| SIZE | Box of 30 x 0.4mL single-use vial |
| INDICATIONS | ACUVAIL® ophthalmic solution is indicated for the treatment of pain and inflammation following cataract surgery. |
| MECHANISM OF ACTION | NSAID (Non-selective COX inhibitor): Inhibits prostaglandin synthesis. |
| MICROBIOLOGY | Ketorolac tromethamine is a nonsteroidal anti-inflammatory drug which, when administered systemically, has demonstrated analgesic, anti-inflammatory, and anti-pyretic activity. The mechanism of its action is thought to be due to its ability to inhibit prostaglandin biosynthesis. |
| CONTRAINDICATIONS & WARNINGS | Delayed Healing, Epithelial breakdown, corneal thinning, corneal erosion, corneal ulceration or corneal perforation possible in susceptible patients. |
| Hypersensitivity to any of the ingredients in the formulation. Possible cross-sensitivity to acetylsalicylic acid, phenylacetic acid derivatives, and other nonsteroidal anti-inflammatory agents. | |
| PEDIATRIC USE | Safety and effectiveness in pediatric patients have not been established. |
| PREGNANCY | Category C Teratogenic Effects: There are no adequate and well-controlled studies in pregnant women. ACUVAIL solution should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. |
| NOTE | BAK and edetate free. Carboxymethylcellulose increases comfort and extends contact period. |